6 (1) The amount the executive officer shall pay under subsection 5 (1) in respect of a listed drug product is the amount calculated by adding the amounts determined under paragraphs 1, 2 and 3, subtracting from that total the maximum co-payment that may be charged in respect of the supplying of a listed drug product for an eligible person, as provided for in the regulations, and by further subtracting from that amount any additional amount determined by the executive officer in accordance with the regulations: 1.  The dispensing fee determined under subsection (2). 2.  The drug benefit price for the drug product, but, if there are other listed drug products that are interchangeable with the drug product, the drug benefit price shall be deemed to be the lowest of the drug benefit prices for the drug product and the listed drug products that are interchangeable with it. 3.  The applicable prescribed mark-up on that price.  2006, c. 14, s. 12 (1); 2009, c. 26, s. 19 (4); 2017, c. 8, Sched. 24, s. 1; 2019, c. 15, Sched. 28, s. 1. Dispensing fee (2) The dispensing fee the executive officer shall pay to operators of pharmacies under subsection (1) for dispensing listed drug products for eligible persons shall be, (a)  Repealed:  2006, c. 14, s. 12 (3). (b)  where the listed drug product does not require a prescription for sale and is designated as one to which this clause applies, no dispensing fee; and (c)  in all other cases, the lesser of, (i)  the applicable dispensing fee prescribed by the regulations, and (ii)  the amount the operator sets under subsection 6 (1) of the Drug Interchangeability and Dispensing Fee Act.  R.S.O. 1990, c. O.10, s. 6 (2); 1996, c. 1, Sched. G, s. 6 (2-5); 2006, c. 14, s. 12 (2, 3); 2009, c. 26, s. 19 (5). Same, high acquisition cost (3) Subject to the prescribed conditions, if any, if the acquisition cost of a listed drug product for an operator of a pharmacy is greater than the sum of the drug benefit price for the drug product determined under paragraph 2 of subsection (1) and the mark-up on that price, referred to in paragraph 3 of subsection (1), the executive officer shall also pay, under subsection 5 (1), the difference between the acquisition cost for the drug product and that sum.  2006, c. 14, s. 12 (4). Interchangeable products (4) For the purpose of subsection (3), if an operator of a pharmacy dispenses a listed drug product that is interchangeable with other listed drug products, the acquisition cost of the listed drug product that is dispensed is the lowest acquisition cost from among the drug product dispensed and the listed drug products in the operator’s inventory that are interchangeable with the drug product.  1996, c. 1, Sched. G, s. 6 (6). No substitution prescription (5) If a listed drug product is supplied pursuant to a prescription that includes a direction that there be no substitutions and that meets the prescribed conditions, subsections (3) and (4) do not apply and the executive officer shall also pay, under subsection 5 (1), the amount determined under subsection 4 (5).  1996, c. 1, Sched. G, s. 6 (6); 2006, c. 14, s. 12 (5). Section Amendments with date in force (d/m/y) 1996, c. 1, Sched. G, s. 6 (1, 3, 5, 6) - 27/05/1996; 1996, c. 1, Sched. G, s. 6 (2) - 30/01/1996; 1996, c. 1, Sched. G, s. 6 (4) - 01/03/1996 2006, c. 14, s. 12 (1-5) - 01/10/2006 2009, c. 26, s. 19 (4, 5) - 15/03/2010 2017, c. 8, Sched. 24, s. 1 (1) - 01/09/2017; 2017, c. 8, Sched. 24, s. 1 (2) - 01/09/2019 2019, c. 15, Sched. 28, s. 1 - 01/01/2020 7 Repealed:  1996, c. 1, Sched. G, s. 7 (1). Note: No process under section 7 initiated or under way on or before January 30, 1996 shall continue after that day.  See: 1996, c. 1, Sched. G, s. 7 (2). Section Amendments with date in force (d/m/y) 1996, c. 1, Sched. G, s. 7 (1) - 30/01/1996 8 Repealed:  2006, c. 14, s. 13. Section Amendments with date in force (d/m/y) 1996, c. 1, Sched. G, s. 8 (1, 2) - 27/05/1996 2006, c. 14, s. 13 - 01/10/2006